Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
NIDA Home > Funding

American Recovery and Reinvestment Act of 2009 (Recovery Act)

Recovery Act Limited Competition: Supporting New Faculty Recruitment to Enhance Research Resources through Biomedical Research Core Centers (P30)
(RFA-OD-09-005)
National Institute on Drug Abuse

This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 ("Recovery Act" or "ARRA"), Public Law 111-5, invites applications from U.S academic institutions/organizations for developing resources to support research projects within the context of Biomedical Research Core Centers. Specifically, Core Center Grants are institutional awards that provide support for shared resources for categorical research by investigators from different disciplines who provide a multidisciplinary approach to a joint research effort, or from the same discipline who focus on a common research problem.

This initiative is one of several being offered by NIDA to help fulfill the goals of the American Recovery and Reinvestment Act (ARRA) to help stimulate the economy through support of biomedical and behavioral research. Additional information the Recovery Act and related NIH opportunities is available through the Office of Extramural Research http://grants.nih.gov/recovery/

Areas of Scientific Priority:

The National Institute on Drug Abuse (NIDA) offers the P30 Core Center Grant program for the recruitment of faculty members conducting drug abuse and addiction research. Applicants that are hiring new faculty in these underrepresented areas of drug abuse and addiction research will be given additional consideration:

  • Medications Development
  • Vaccines
  • Biomarkers
  • Chemistry
  • Neuroinformatics
  • Underrepresented Populations
  • Clinical Research
  • Inter- and Transdisciplinary Research
  • Comorbidity
  • Genetics & Epigenetics
  • HIV/AIDS
  • Brain Development and Genetics
  • Neuroeconomics

Applications should specify the department(s) or center(s) in which this P30 capacity building will be focused.

Eligibility: Eligible organizations include U.S. public or private institutions of higher education.

Number of applications: Only one application per institution will be accepted.

Other information: Applicant institutions should plan to hire new faculty within the first year of receiving the award; i.e. faculty candidate(s) should accept the institution's offer of employment within 1 year of the project start date. Faculty hires who begin their new employment more than 90 days prior to the initial budget period (see RFA for terms of pre-award costs) will not be considered new hires under this initiative.

NIDA requires that any faculty members hired under this initiative receive joint appointment(s) with other academic unit(s) at the applicant institution, allowing new faculty to access University-wide research resources and core facilities, and to serve as mentors for graduate programs affiliated with other academic unit(s).

Funds Available and Anticipated Number of Awards. NIDA expects to make between 4 and 5 awards during FY 2009, with total funding of approximately $7 million over the two-year period of FY 2009 and 2010.

Budget and Project Period. Budgets for direct costs of up to $500,000 per year and project duration of up to two years may be requested, for a maximum of $1,000,000 direct costs over a two-year project period.

Key Dates:

Release Date: March 30, 2009
Letters of Intent Receipt Date: April 29, 2009
Application Receipt Date: May 29, 2009
Peer Review Date: July 2009
Council Review Date: August 2009
Earliest Anticipated Start Date: September 30, 2009
Expiration Date: May 30, 2009

Contact Information:

Program Contact(s): Mimi M. Ghim, PhD
Phone 301-443-6071
Email: ghimm@nida.nih.gov

Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Jane Acri, jacri@nida.nih.gov
Jamie Biswas,jbiswas@nida.nih.gov

Division of Basic Neuroscience and Behavioral Research
Beth Babecki, bbabecki@nida.nih.gov

Division of Epidemiology, Services and Prevention Research
Aria Crump,acrump@nida.nih.gov

Division of Clinical Neuroscience and Behavioral Research
Debbie Grossman, dgrossma@nida.nih.gov

AIDS Research Program
Diane Lawrence,lawrencedi@nida.nih.gov

Grants Management Contact(s): Pamela G. Fleming
Phone (301) 253-8729
Email: pfleming@nida.nih.gov

Letters of Intent Contact:
Please send letters to NIDAletterofintent@mail.nih.gov.
With subject line: "RFA-OD-09-005"

Review Contact:
Teresa Levitin, Ph.D.
Telephone: (301) 443-2755
E-mail: TL25u@NIH.GOV

Additional Resources



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal